Diadema Partners LP Amgen Inc Transaction History
Diadema Partners LP
- $383 Billion
- Q1 2025
A detailed history of Diadema Partners LP transactions in Amgen Inc stock. As of the latest transaction made, Diadema Partners LP holds 103,300 shares of AMGN stock, worth $30.3 Million. This represents 8.4% of its overall portfolio holdings.
Number of Shares
103,300Holding current value
$30.3 Million% of portfolio
8.4%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AMGN
# of Institutions
3,310Shares Held
429MCall Options Held
8.06MPut Options Held
7.7M-
Vanguard Group Inc Valley Forge, PA52.9MShares$15.5 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.5 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.2MShares$8.56 Billion0.38% of portfolio
-
Capital World Investors Los Angeles, CA16.7MShares$4.9 Billion0.88% of portfolio
-
Morgan Stanley New York, NY16.2MShares$4.76 Billion0.37% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $157B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...